Alcon Inc. is a Switzerland-based manufacturer and distributor of eye care products and surgical equipment serving ophthalmology markets globally. The company researches, develops, and sells a comprehensive portfolio of surgical devices, diagnostic instruments, implantable products, and vision care solutions for cataract procedures, refractive surgery, vitreoretinal interventions, and general ocular health. Its product range includes intraocular lenses, surgical microscopes, laser systems, diagnostic biometers, and digital visualization platforms alongside contact lenses, dry eye treatments, and ocular pharmaceuticals.
The company operates through two primary segments. The Surgical segment provides equipment, instrumentation, and consumable materials used in eye procedures, including cataract surgery platforms such as the LenSx laser system and ARGOS biometer, vitreoretinal surgery systems, and refractive surgery products. The Vision Care segment offers daily disposable and reusable contact lenses, ocular health products addressing conditions such as dry eye and glaucoma, and ancillary eye care treatments.
Alcon employs approximately 25,942 full-time employees and maintains operations across multiple geographic regions to serve hospitals, surgical centers, and retail eye care providers. The company was founded in 1945 and became publicly listed on the New York Stock Exchange following its 2001 incorporation restructuring.
No 10-K filings found.